MediPharm Labs (STU:MLZ) Total Stockholders Equity : €33.89 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is MediPharm Labs Total Stockholders Equity?

MediPharm Labs's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €33.89 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. MediPharm Labs's Book Value per Share for the quarter that ended in Mar. 2024 was €0.08. The ratio of a company's debt over equity can be used to measure how leveraged this company is. MediPharm Labs's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.04.

MediPharm Labs Total Stockholders Equity Historical Data

The historical data trend for MediPharm Labs's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediPharm Labs Total Stockholders Equity Chart

MediPharm Labs Annual Data

Trend

Sep17

Sep18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

89.90

50.32

57.49

38.92

36.23

MediPharm Labs Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															36.63	41.00	38.23	36.23	33.89

MediPharm Labs (STU:MLZ) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

MediPharm Labs's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(33.885	-	0)	/	404.049
	=	0.08

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

MediPharm Labs's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.398	+	0.039)	/	33.885
	=	0.04

MediPharm Labs Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of MediPharm Labs's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

MediPharm Labs (STU:MLZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MediPharm Labs Corp (STU:MLZ) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

MEDIF:USA MLZ:Germany LABS:Canada

Address

151 John Street, Barrie, ON, CAN, L4N 2L1

Website

https://www.medipharmlabs.com

MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis extracts and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.

MediPharm Labs (STU:MLZ) Headlines

No Headlines